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Ⅰ．Introduction
 Kidney transplantation （KTx） in infants （body 
weight ［BW］ ＜10 kg, and/or body surface area 
［BSA］ ＜0.5 m2） starting dialysis in the neonatal period 
is an emergency intervention for unstable efficacy of 
dialysis and possible loss of peritoneal/vascular access 
for dialysis［1,2］. Even among this patient population, 
recent, sophisticated, pre- and post-transplant, medical, 
surgical, and multi-disciplinary interventions have 
impoved short-term renal allograft survival within 
five years after KTx［3-5］. In contrast, several studies 
reported an early phase of chronic allograft ischemia 
（CAI） in adult-sized kidneys （ASKs） transplanted into 
small children （BW ＜15 kg, and/or BSA ＜0.75 m2） 
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Abstract
Kidney transplantation （KTx） in infants （body weight ［BW］ ＜10 kg and/or body surface 
area ［BSA］ ＜0.5 m2） is an accepted treatment option for chronic kidney disease in children and has 
demonstrated excellent short-term graft survival. However, follow-up studies longer than five years are 
still lacking. We experienced a case of an infant （BW 9.2 kg, BSA 0.44 m2） with an adult-sized kidney 
（ASK） transplant （donor-recipient height ratio: 2.24） which resulted in graft loss at 9.7 years after the 
transplant secondary to biopsy-proven chronic allograft ischemia （CAI）. Intensive maintenance fluid 
supplementation failed to prevent ongoing and long-standing graft hypoperfusion. While the decrease 
in the estimated glomerular filtration rate （eGFR） was irregular, the progression of chronic changes 
seen in the graft biopsies was linear, both in early- and late-phase KTx. CAI in significantly size-
mismatched ASKs transplanted into infants can promote late graft failure within ten years. Since serial 
evaluations of renal histology were shown to be a better indicator of renal graft outcomes throughout 
the post-transplant course, transplant surveillance biopsies beyond the early phase of KTx may assist 
in elucidating the natural course of CAI in ASKs transplanted into infant recipients.
　Key words:  Kidney transplantation, infant, adult-sized kidney, chronic allograft ischemia, long-term 
graft survival
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due to the considerable donor-recipient size mismatch, 
represented by donor-recipient BSA or height ratio ≥1.8 
to 2.0［6-10］. Among these studies, two demonstrated 
a correlation between the increasing degree of size-
mismatch and increasing evidence of ischemic changes 
in allograft biopsies developing as early as one year 
post-transplant and progressing steadily over the next 
two years［8,11］. It is theoretically predicted that more 
rapid progression of ischemic change and shorter graft 
survival will be exhibited in more size-discrepant KTx, 
i.e., ASK transplantation in ‘infants’, the further special 
group of small children, with donor-recipient BSA or 
height ratio ≥2.2 to 2.5; however, the actual longitudinal 
effect of CAI on graft survival in this special KTx 
category has yet to be described［12］. We herein report 
CAI causing late graft loss relatively sooner （＜10 
years） in an infant with an ASK transplant over a decade 
of continuous observation. A series of scheduled and 
clinically indicated graft biopsies over the time period 
enabled more accurate monitoring of graft function than 
the serum creatinine （SCr）-based estimated glomerular 
filtration rate （eGFR）. 
Ⅱ．Case
 A female infant was born at 35 weeks of gestation 
with a birth weight of 2846 g via urgent cesarean 
section for progressive oligohydramnios, which 
presented immediately prior to delivery. Her clinical 
course was complicated by severe asphyxia due to 
dry lung syndrome, total anuria, severe hypertension, 
and abdominal compartment with bilateral enlarged 
kidneys. The patient required ventilator support, 
peritoneal dialysis （PD）, and bilateral nephrectomy. 
The  histology of her native kidneys and an examination 
of her parents’ bilateral kidneys confirmed the diagnosis 
of autosomal recessive polycystic kidney disease. 
Intensive, continuous cycling PD and aggressive 
nutritional support enabled growth within the minimally 
acceptable range. At around age 12 months, she 
experienced peritoneal membrane failure, multiple 
thromboses in the central veins, and subsequently, 
underdialyzed status, which prompted us to perform 
a living related KTx from her mother. The patient 
underwent transplant surgery at age 14 months. Her BW 
at the time was 9.3 kg （+0.3 standard deviation ［SD］）, 
her BSA was 0.44 m2, and her height was 68.4 cm （-2.1 
SD）. Her mother’s height was 153.6 cm, giving the 
donor-recipient height ratio of 2.24. The operation was 
successful with immediate graft function, and the patient 
was placed on quadruple immunosuppression consisting 
of basiliximab, tacrolimus, mycophenolate mofetil, 
and methylprednisolone. To minimize hypovolemia, a 
major predisposing factor of renal allograft ischemia in 
this BW/BSA size group, a total daily fluid intake of 
2500-3000 mL/m2/day with a sodium intake of at least 
10 mEq/kg/day via nasogastric tube was maintained. 
The volume of fluids were strictly titrated according 
to her clinical hydration status and Scr levels as 
previously recommended［8,13］. To avoid dehydration, 
adequate intravenous isotonic fluids were supplemented 
immediately at every occurrence of common airway 
or gastrointestinal viral illness. This fluid management 
was continued for more than six years until stage G4 
chronic kidney disease （CKD）, i.e., the eGFR of 15-
20 mL/min/1.73 m2, developed, at which time dialysis 
was begun again. Throughout the course, she experience 
no dehydration-associated hypotension or medication- 
or graft dysfunction-related hypertension until the 
development of Stage G4 CKD. Her SCr levels were 
stable at 0.29-0.31 mg/dL until three years post-KTx. 
Her eGFR, calculated using a formula developed for 
Japanese children based on SCr and height［14］, was 
also stable. However, at 9.7 years post-KTx her eGFR 
fell to zero （Fig. 1）. She underwent a graft biopsy 
at one hour, one year, two years, and five years post-
KTx as surveillance, and at three and six years post-
KTx due to an asymptomatic increase in the SCr. 
Surprisingly, all the histological findings of the biopsies 
during the entire course were nearly identical, showing 
predominantly interstitial fibrosis and tubular atrophy 
（IFTA） disproportionate to glomerular structural 
changes and indicative of ischemic nephropathy［15］
（Fig. 2）. While the eGFR remained at nearly the same 
level for a certain period and then dropped abruptly in 
a stepwise manner, the histologically preserved area of 
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the core biopsy specimen （the actual functioning area） 
declined linearly from the early to late post-KTx period, 
i.e., IFTA progressed steadily from ci 0 to ci 3 and 
ct0 to ct3 of the Banff Classification［16］, showing a 
considerable difference between the graft histology and 
the eGFR. The degree of IFTA change was far greater 
than the GFR decrease not only between years 2 and 
3, but also between years 5 and 6 post-KT （Fig. 1）. 
Serial histological findings and blood/urine tests denied 
the following possible causes of chronic renal allograft 
injury other than CAI: T cell-/antibody-mediated 
rejection, acute/chronic calcineurin inhibitor toxicity, de 
novo renal diseases, and latent viral infections caused 
by cytomegalovirus/Epstein-Barr virus/polyomavirus. 
At each biopsy, the ongoing ischemic process prompted 
us aggressively to reinforce the fluid regimen. After all 
our efforts failed to slow the progression of this process, 
dialysis was resumed at 7.5 years post-KTx, and the 
patient became totally anuric two years after resuming 
dialysis. 
Ⅲ．Discussion
 This patient’s course provided two important clinical 
suggestions. First, CAI in significantly size-mismatched 
ASKs transplanted into infants can produce progressive 
loss of graft function within ten years post-KTx. Second, 
a renal histology is a better tool for assessing and 
predicting long-term renal allograft function than the 
eGFR throughout the post-KTx course.
 First, continuous hypoperfusion of ASK allografts 
in infants （＜10 kg, BSA ＜0.5 m2） can be not only 
an important cause of chronic renal allograft injury, 
but also give rise to earlier late graft loss within ten 
years after KTx. As a mechanism of ischemic allograft 
dysfunction, previous studies demonstrated that ASKs 
transplanted into small children （＜15 kg, BSA ＜0.75 
m2） resulted in inadequate blood flow, leading to the 
development of adaptive hypotrophy and failure to 
increase in size parallel to the patient’s maturation; 
histological results demonstrated IFTA at three months 
post-KTx which gradually progressed over one to two 
years［8,10,11,13,17-19］; however, given the short-
term （＜5 years post-KTx） nature of the results and 
no differentiation between infants and small children 
in these studies, the impact of CAI on long-term （＞5 
years post-KTx） ASK allograft function in infants has 
yet to be clarified. The most recent studies with a large 
cohort have demonstrated improved ten-year graft 
survival rates of 74.0-81.1% in KTx in small children, 
which were equivalent to the results in older pediatric 
recipients［3,5,6,20］. Nonetheless, these reports did 
not specify the detailed recipient sizes or etiologies of 
Fig. 1　 Course of eGFR changes and the histologically 
preserved （morphologically functioning） area in 
the core biopsy specimen （100%-%IFTA）
Numbers within the parenthesis next to the labels on the 
horizontal axis indicate post-transplant years. 
KTx: kidney transplantation, eGFR: estimated glomerular 
filtration rate, IFTA: interstitial fibrosis and tubular 
atrophy, : %IFTA indicates the proportion of the graft core 
biopsy specimen showing interstitial fibrosis and tubular 
atrophy. 
Fig. 2　 Two graft biopsies at one year （a） and three years 
（b） post-transplant （Periodic acid–Schiff ［PAS］ 
stain, magnification ×400）
Both show chronic ischemic nephropathy characterized 
by interstitial fibrosis and tubular atrophy （IFTA） 
with relatively preserved glomerular structures. IFTA, 
already presenting at one year post-transplant, progressed 
significantly at three years post-transplant, while eGFR 
was unaffected during the period between the two time 
points.  
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of improved outcomes via longitudinal biopsies with 
prescheduled points in time from several months 
to a dacade after KTx regardless of the recipients’ 
conditions, detecting modifiable conditions: subclinical 
acute cellular rejection （3 to 6 months after KTx）, 
acute and chronic antibody-mediated rejection （a year 
to a decade after KTx）, hypertension （a year to a 
decade after KTx）, and chronic dehydration （as seen 
in this case report, 3 months to a decade after KTx）
［24,25］. In our report, IFTA progression continued to 
be steady and predictable, while the eGFR decrease 
continued to be unstable and unpredictable for a decade. 
This finding emphasizes the importance of long-term 
histopathological evaluation via surveillance biopsy 
for ASK KTx in infants. Suggested timing of protocol 
biopsies in selected pediatric KTx recipients of the high 
risk group both for immunologic and non-immunologic 
graft loss may include time points of 1 hour （for 
baseline findings）, 3 to 6 months, 1 year, 3 years, 5 
years, 7 years and a dacade after KTx. 
 In conclusion, significantly size-mismatched 
ASK KTx in infants may lead to progressive chronic 
ischemic renal allograft injury as a late complication. 
Histopathological examination of IFTA may be superior 
to the eGFR as an indicator of allograft function 
immediately after a transplant and in succeeding 
years. Further studies are needed to determine whether 
distinctly size-mismatched ASK infant recipients 
manifest an earlier decline in graft function secondary 
to CAI and whether long-term protocol biopsies beyond 
five years post-KTx may help elucidate the natural 
course of CAI in ASK KTx in infants since a renal 
histology may an appropriate tool for evaluating graft 
function.  
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graft failure accounting for approximately 20-25% of 
the graft loss cases; infants with CAI would likely have 
been a significant proportion of the graft loss population. 
Two studies demonstrated a mean rate of eGFR decrease 
in small children with KTx of 70-75 （ml/min/1.73 m2）, 
55-60, and 40-45, at one, five, and ten years post-KTx, 
respectively. However, since the data on infants were not 
differentiated from those on small children［6,7］, little is 
known with regard to the eGFR decrease rate in infants. 
One study reported that a donor-recipient height ratio of 
more than 2.2, mostly seen in ASKs transplanted into 
infants, was a high risk factor for graft loss within ten 
years［20］. This finding may corroborate the findings 
of our study that CAI may cause earlier late graft loss 
within a decade of transplantation in a case of infantile 
ASK KTx. In this case, the rate of eGFR decrease may 
be proportional to, or even exponentially greater, than 
the degree of the size mismatch. 
 Second, the renal histology of the interstitial fibrosis 
and tubular atrophy （IFTA） was a more sensitive and 
accurate indicator of actual renal function than the 
eGFR, both in the earlier and later post-KTx phases 
（＞5 years）. Two single center reports based on two- 
and five-year protocol graft biopsies in pediatric KTx 
demonstrated a fairly modest but statistically significant 
correlation between IFTA progression and eGFR 
decrease［9,21］; however, apart from the short-term 
nature of this finding, the authors were also concerned 
that the statistical power of their results was too weak 
to allow reliable clinical interpretation. Another short-
term study showed the superiority of surveillance graft 
biopsy findings to the eGFR by evaluating the actual 
functional status of pediatric KTx allografts［22］; later, 
the same authors suggested the need for long-term, 
serial surveillance biopsies for size-mismatched ASKs 
in infants and small children［23］. To date, more than 
60% of pediatric KTx centers undertake only indication 
biopsies at the time of the abrupt eGFR decline during 
the follow up, much debating long-term benefits, timing, 
and safety of surveillance （protocol） biopsies; its’ 
timing and duration, if advocated, also vary depending 
upon the individual KTx centers, accordingly. However, 
several recent reports have demonstrated some evidence 
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